AR and prostate carcinoma: Clinical evidence supports this hypothesis: low circulating testosterone and estradiol levels are associated with a higher risk of high-grade prostate cancer 36, and chronic androgen deprivation may promote castration-resistant phenotypes through androgen receptor-related signaling involving receptor overexpression, mutations, ligand-independent activation, and bypass pathways 4, 5.